Titania nanotube-based protein delivery system to inhibit cranial bone regeneration in Crouzon model of craniosynostosis

References

• Coussens AK, Wilkinson CR, Hughes IP, et al. Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis. BMC Genomics. 2007;8(1):458–482. doi:10.1186/1471-2164-8-45818076769
   PubMedGoogle Scholar
• Dwivedi P, Grose R, Hii C, Filmus C, Anderson P, Powell B. Regulation of bone morphogenetic protein signalling and osteogenesis by glypicans in human cranial suture cells. Bone. 2013;48(2):243–254. doi:10.1016/j.bone.2011.03.588
   Google Scholar
• Wilkie AO. Craniosynostosis: genes and mechanisms. Hum Mol Gen. 1997;6:1647–1656. doi:10.1093/hmg/6.10.16479300656
   PubMed Web of Science ®Google Scholar
• Gosain AK, McCarthy JG, Wisoff JH. Morbidity associated with increased intracranial pressure in Apert and Pfeiffer syndromes: the need for long-term evaluation. Plast Reconstr Surg. 1996;97(2):292–301.8559811
   PubMed Web of Science ®Google Scholar
• Gonsalez S, Hayward R, Jones B, Lane R. Upper airway obstruction and raised intracranial pressure in children with craniosynostosis. Eur Respir J. 1997;10(2):367–375.9042634
   PubMed Web of Science ®Google Scholar
• Panchal J, Uttchin V. Management of craniosynostosis. Plast Reconstr Surg. 2003;111(5):2032–2048. doi:10.1097/01.PRS.0000056839.94034.4712711969
   PubMedGoogle Scholar
• Hermann CD, Hyzy SL, Olivares-Navarrete R, et al. Craniosynostosis and resynostosis: models, imaging, and dental implications. J Dent Res. 2016;95(8):846–852. doi:10.1177/002203451664331527076448
   PubMedGoogle Scholar
• Mooney MP, Moursi AM, Opperman LA, Siegel MI. Cytokine therapy for craniosynostosis. Expert Opin Biol Ther. 2004;4(3):279–299. doi:10.1517/14712598.4.3.27915006724
   PubMed Web of Science ®Google Scholar
• Derderian C, Seaward J. Syndromic craniosynostosis. Semin Plast Surg. 2012;26(2):64–75. doi:10.1055/s-0032-132006423633933
   PubMedGoogle Scholar
• Dwivedi P, Lam N, Powell B. Boning up on glypicans - opportunities for new insights into bone biology. Cell Biochem Funct. 2013;31(2):91–114. doi:10.1002/cbf.293923297043
   PubMedGoogle Scholar
• Cooper GM, Curry C, Barbano TE, et al. Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Min Res. 2007;22(7):1046–1054. doi:10.1359/jbmr.070410
   PubMed Web of Science ®Google Scholar
• Cooper GM, Usas A, Olshanski A, Mooney MP, Losee JE, Huard J. Ex vivo Noggin gene therapy inhibits bone formation in a mouse model of postoperative resynostosis. Plast Reconstr Surg. 2009;123(2 Suppl):S94–S103. doi:10.1097/PRS.0b013e318191c05b
   Web of Science ®Google Scholar
• Cray J, Burrows AM, Vecchione L, et al. Blocking bone morphogenetic protein function using in vivo noggin therapy does not rescue premature suture fusion in rabbits with delayed-onset craniosynostosis. Plast Reconstr Surg. 2011;127(3):1163–1172. doi:10.1097/PRS.0b013e318205f23b21364419
   PubMedGoogle Scholar
• Coussens AK, Hughes IP, Wilkinson CR, et al. Identification of genes differentially expressed by prematurely fused human sutures using a novel in vivo – in vitro approach. Differentiation. 2008;76(5):531–545. doi:10.1111/j.1432-0436.2007.00244.x18093228
   PubMedGoogle Scholar
• Khominsky A, Yong R, Ranjitkar S, Townsend GC, Anderson P. Extensive phenotyping of orofacial features in Crouzon syndrome. Arch Oral Biol. 2018;86:123–130. doi:10.1016/j.archoralbio.2017.10.02229223639
   PubMedGoogle Scholar
• Bariana M, Dwivedi P, Ranjitkar S, Kaidonis JA, Losic D, Anderson PJ. Glypican-based drug releasing titania implants to regulate BMP2 bioactivity as a potential approach for craniosynostosis therapy. Nanomedicine. 2018;14:2365–2374. doi: 10.1016/j.nano.2017.06.005
   PubMed Web of Science ®Google Scholar
• Bariana M, Dwivedi P, Ranjitkar S, Kaidonis JA, Losic D, Anderson PJ. Biological response of human suture mesenchymal cells to Titania nanotube-based implants for advanced craniosynostosis therapy. Colloids Surf B. 2017;150:59–67. doi:10.1016/j.colsurfb.2016.11.019
   PubMed Web of Science ®Google Scholar
• Gulati K, Aw M, Losic D. Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. Int J Nanomed. 2012;7:2069–2076.
   PubMed Web of Science ®Google Scholar
• Gulati K, Prideaux M, Kogawa M, et al. Anodized 3D-printed titanium implants with dual micro- and nano-scale topography promote interaction with human osteoblasts and osteocyte-like cells. J Tissue Eng Regen Med. 2017;11:3313–3325. doi:10.1002/term.223927925441
   PubMed Web of Science ®Google Scholar
• Maher S, Kaur G, Lima-Marques L, Evdokiou A, Losic D. Engineering of micro- to nanostructured 3D-Printed drug-releasing titanium implants for enhanced osseointegration and localized delivery of anticancer drugs. ACS Appl Mater Interfaces. 2017;9(35):29562–29570. doi:10.1021/acsami.7b0991628820570
   PubMed Web of Science ®Google Scholar
• Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomateials. 2007;28(21):3188–3197. doi:10.1016/j.biomaterials.2007.03.020
   PubMed Web of Science ®Google Scholar
• von Wilmowsky C, Bauer S, Lutz R, et al. In vivo evaluation of anodic TiO2 nanotubes: an experimental study in the pig. J Biomed Mater Res B. 2009;89(1):165–171. doi:10.1002/jbm.b.31201
   Google Scholar
• Bjursten LM, Rasmusson L, Oh S, Smith GC, Brammer KS, Jin S. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A. 2010;92(3):1218–1224. doi:10.1002/jbm.a.3246319343780
   PubMedGoogle Scholar
• Moioli EK, Clark PA, Xin X, Lal S, Mao JJ. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev. 2007;59(4–5):308–324. doi:10.1016/j.addr.2007.03.01917499385
   PubMedGoogle Scholar
• Springer IN, Warnke PH, Terheyden H, et al. Craniectomy and noggin application in an infant model. J Craniomaxillofac Surg. 2007;35(3):177–184. doi:10.1016/j.jcms.2007.04.00317582779
   PubMed Web of Science ®Google Scholar
• Shen K, Krakora S, Cunningham M, et al. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model. Orthod Craniofac Res. 2009;12(3):254–262. doi:10.1111/j.1601-6343.2009.01460.x19627528
   PubMedGoogle Scholar
• Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol. 2007;2:16. doi:10.1186/1745-6673-2-1618053152
   PubMedGoogle Scholar
• Garcia LM, Leitune VCB, Kist TL, Takimi A, Samuel SMW, Collares SM. Quantum dots as nonagglomerated nanofillers for adhesive resins. J Dent Res. 2016;95(12):1401–1407. doi:10.1177/002203451665683827422857
   PubMedGoogle Scholar
• Huang J, Zhang X, Yan W, et al. Nanotubular topography enhances the bioactivity of titanium implants. Nanomedicine. 2017;13:1913–1923. doi:10.1016/j.nano.2017.03.01728400159
   PubMedGoogle Scholar
• Li G, Zhou T, Lin S, Shi S, Lin Y. Nanomaterials for craniofacial and dental tissue engineering. J Dent Res. 2017;96(7):725–732. doi:10.1177/002203451770667828463533
   PubMed Web of Science ®Google Scholar
• Lin X, Yang S, Lai K, Yang H, Webster T, Yang L. Orthopedic implant biomaterials with both osteogenic and anti-infection capacities and associated with in vivo evaluation methods. Nanomedicine. 2017;13:123–142. doi:10.1016/j.nano.2016.08.00327553074
   PubMedGoogle Scholar
• Santos A, Aw MS, Bariana M, Kumeria T, Wang Y, Losic D. Drug-releasing implants: current progress, challenges and perspectives. J Mater Chem B. 2014;2:6157–6182. doi:10.1039/C4TB00548A
   PubMed Web of Science ®Google Scholar
• Fretwurst T, Nelson K, Tarnow DP, Wang H-L, Giannobile WV. Is metal particle release associated with peri-implant bone destruction? An emerging concept. J Dent Res. 2018;97(3):259–265. doi:10.1177/002203451774056029130804
   PubMed Web of Science ®Google Scholar
• Halamoda-Kenzaoui B, Holzwarth U, Roebben G, Bogni A. Mapping of the available standards against the regulatory needs for nanomedicines. Nanomed Nanobiotechnol. 2018;e1531. doi:10.1002/wnan.1531
   Web of Science ®Google Scholar
• Lunt SJ, Kalliomaki TM, Brown A, Yang VX, Milosevic M, Hill RP. Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer. 2008;8(1):2–15. doi:10.1186/1471-2407-8-218179711
   PubMedGoogle Scholar
• Lim SM, Song DK, Oh SH, Lee-Yoon DS, Bae EH, Lee JH. In vitro and in vivo degradation behavior of acetylated chitosan porous beads. J Biomater Sci Polym Ed. 2008;19(4):453–466. doi:10.1163/15685620878371948218318958
   PubMed Web of Science ®Google Scholar
• Gulati K, Johnson L, Karunagaran R, Findlay D, Losic D. In situ transformation of chitosan films into microtubular structures on the surface of nanoengineered titanium implants. Biomacromolecules. 2016;17(4):1261–1271. doi:10.1021/acs.biomac.5b0103726999291
   PubMedGoogle Scholar
• Drake DB, Persing JA, Berman DE, Ogle RC. Calvartal deformity regeneration following subtotal craniectomy for craniosynostosis: a case report and theoretical implications. J Craniofac Surg. 1993;4(2):85–89.8324088
   PubMedGoogle Scholar
• Tomihata K, Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 1997;18(7):567–575.9105597
   PubMed Web of Science ®Google Scholar
• Lee JY, Nam SH, Im SY, et al. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release. 2002;78(1–3):187–197.11772460
   PubMed Web of Science ®Google Scholar
• Oktay EO, Demiralp B, Demiralp B, et al. Effects of platelet-rich plasma and chitosan combination on bone regeneration in experimental rabbit cranial defects. J Oral Implantol. 2010;36(3):175–184. doi:10.1563/AAID-JOI-D-09-0002320553171
   PubMed Web of Science ®Google Scholar